AlphaYouTC
Schedule 13G filing
TANG CAPITAL MANAGEMENT LLC disclosed a 6% stake in Atea Pharmaceuticals, Inc. (AVIR)
TANG CAPITAL MANAGEMENT LLC reported owning 6% of Atea Pharmaceuticals, Inc. (AVIR) (4,814,700 shares) in a Schedule 13G filed Oct 6, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 6, 2026
- Source
- Schedule 13G
More AVIR insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.